Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis
Authors:
- 1 August 2006
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 177 (1-2) , 132-135
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Expression of Vascular Adhesion Protein-1 in Atopic EczemaInternational Archives of Allergy and Immunology, 2006
- The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanismsTrends in Immunology, 2005
- Absence of the Endothelial Oxidase AOC3 Leads to Abnormal Leukocyte Traffic In VivoImmunity, 2005
- Blockade of Vascular Adhesion Protein-1 Inhibits Lymphocyte Infiltration in Rat Liver Allograft RejectionThe American Journal of Pathology, 2004
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Circulating adhesion molecules in diseaseImmunology Today, 1993
- A 90-Kilodalton Endothelial Cell Molecule Mediating Lymphocyte Binding in HumansScience, 1992
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983